Aligos Therapeutics ALGS
NASDAQ ALGS
$2.10 +0.12 (+6.06%)
At close: Nov 13, 2026 · 4:00 PM EST

Aligos Therapeutics (ALGS) Other Non Operating Income (2021 - 2026)

Updated

Aligos Therapeutics' Other Non Operating Income came in at -$1,000 for Q2 2026, compared with -$27,000 a year earlier.

Analysis

Aligos Therapeutics (ALGS) Other Non Operating Income (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Aligos Therapeutics reported Other Non Operating Income of -$62,000; for FY2024, it was -$46.13 million.

  • Going back by year, Other Non Operating Income was -$2.17 million in FY2023, $119.00 in FY2022, -$110.00 in FY2021 and -$11.8 million in FY2020.
  • The Q2 2026 figure represents the highest quarterly Other Non Operating Income in data going back to Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Aligos Therapeutics 21.97 Mn -314.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,000.00
Mar 31, 2026 -30,000.00
Jun 30, 2025 -27,000.00
Mar 31, 2025 -4,000.00
Mar 31, 2024 -69,000.00
Jun 30, 2022 -154,000.00
Mar 31, 2022 -248,000.00
Jun 30, 2021 -24,000.00
Mar 31, 2021 -39,000.00
API Access

Aligos Therapeutics Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=ALGS&period=max&api_key=YOUR_API_KEY